Structures by: Pandey M. K.
Total: 41
4(N,N-Dimethylamino)pyridinium 3-Nitrobenzoate
C7H4NO4,C7H11N2
IUCrJ (2017) 4, 4
a=28.685(15)Å b=6.783(3)Å c=13.975(7)Å
α=90.00° β=94.175(7)° γ=90.00°
4(N,N-Dimethylamino)pyridinium 3-Nitrobenzoate
C7H4NO4,C7H11N2
IUCrJ (2017) 4, 4
a=28.86(2)Å b=6.791(5)Å c=14.243(10)Å
α=90.00° β=95.4097(10)° γ=90.00°
4-Ethylpyridinium 3,5-Dinitrobenzoate
C7H3N2O6,C7H10N
IUCrJ (2017) 4, 4
a=8.439(6)Å b=14.091(9)Å c=12.167(8)Å
α=90.00° β=95.500(11)° γ=90.00°
4-Ethylpyridinium 3,5-Dinitrobenzoate
C7H3N2O6,C7H10N
IUCrJ (2017) 4, 4
a=8.574(9)Å b=14.346(15)Å c=12.190(13)Å
α=90.00° β=94.440(13)° γ=90.00°
3-Ethylpyridine 4-Nitrobenzoic acid
C7H5NO4,C7H9N
IUCrJ (2017) 4, 4
a=6.631(5)Å b=7.032(6)Å c=14.216(12)Å
α=87.967(17)° β=88.58(3)° γ=80.207(18)°
3-Ethylpyridine 4-Nitrobenzoic acid
C7H5NO4,C7H9N
IUCrJ (2017) 4, 4
a=6.7302(16)Å b=7.1859(17)Å c=14.298(3)Å
α=88.158(6)° β=88.340(6)° γ=78.636(5)°
4-Methylpyridinium Pentachlorophenolate
C6Cl5O,C6H8N
IUCrJ (2017) 4, 4
a=7.389(8)Å b=8.922(8)Å c=12.014(12)Å
α=69.82(3)° β=85.61(4)° γ=76.26(4)°
4-Methylpyridine Pentachlorophenol
C6HCl5O,C6H7N
IUCrJ (2017) 4, 4
a=7.3382(8)Å b=8.8986(9)Å c=11.8245(11)Å
α=69.945(5)° β=85.055(5)° γ=76.133(5)°
4-Methylpyridine Pentachlorophenol
C6HCl5O,C6H7N
IUCrJ (2017) 4, 4
a=7.3857(8)Å b=8.9202(10)Å c=12.0227(12)Å
α=69.770(3)° β=85.869(3)° γ=76.324(4)°
C38H29N3P2
C38H29N3P2
RSC Advances (2018) 8, 45 25704
a=15.5170(11)Å b=11.9307(7)Å c=18.3226(15)Å
α=90° β=111.801(9)° γ=90°
C42H29MoN3O4P2,CHCl3
C42H29MoN3O4P2,CHCl3
RSC Advances (2018) 8, 45 25704
a=14.1841(3)Å b=11.2966(2)Å c=25.2699(6)Å
α=90° β=97.008(2)° γ=90°
C42H29AuClN3O4P2W
C42H29AuClN3O4P2W
RSC Advances (2018) 8, 45 25704
a=12.5915(3)Å b=20.0214(6)Å c=15.3286(4)Å
α=90° β=92.147(2)° γ=90°
C42H29N3O4P2W,CHCl3
C42H29N3O4P2W,CHCl3
RSC Advances (2018) 8, 45 25704
a=14.1865(3)Å b=11.2881(3)Å c=25.1974(9)Å
α=90° β=97.169(2)° γ=90°
C38H29Cl2N3P2Pd,CHCl3
C38H29Cl2N3P2Pd,CHCl3
RSC Advances (2018) 8, 45 25704
a=13.3510(4)Å b=11.0729(2)Å c=25.9296(6)Å
α=90° β=95.690(2)° γ=90°
C38H29Cl2N3P2Pt,CHCl3
C38H29Cl2N3P2Pt,CHCl3
RSC Advances (2018) 8, 45 25704
a=10.2544(3)Å b=12.3816(4)Å c=28.9853(11)Å
α=90° β=90° γ=90°
C42H29N3O4P2W
C42H29N3O4P2W
RSC Advances (2018) 8, 45 25704
a=12.6150(6)Å b=13.3420(9)Å c=14.0151(8)Å
α=71.437(5)° β=69.756(5)° γ=65.940(5)°
C38H29Au2Cl2N3P2,CHCl3
C38H29Au2Cl2N3P2,CHCl3
RSC Advances (2018) 8, 45 25704
a=12.7791(5)Å b=14.3916(6)Å c=20.6657(8)Å
α=90° β=95.247(4)° γ=90°
C48H43ClN3P2Ru,Cl
C48H43ClN3P2Ru,Cl
RSC Advances (2018) 8, 45 25704
a=12.7908(7)Å b=15.2107(10)Å c=15.2959(10)Å
α=114.525(6)° β=103.851(5)° γ=102.567(5)°
2(C43H34ClN3P2Ru),CHCl3
2(C43H34ClN3P2Ru),CHCl3
RSC Advances (2018) 8, 45 25704
a=13.7636(3)Å b=14.7629(4)Å c=22.1839(5)Å
α=76.1417(19)° β=85.9054(18)° γ=85.3961(19)°
C22H38N4O4P4
C22H38N4O4P4
Dalton Transactions (2019)
a=34.968(2)Å b=34.968(2)Å c=6.2485(3)Å
α=90° β=90° γ=120°
C18H28Cl2Cu2N4O2P2
C18H28Cl2Cu2N4O2P2
Dalton Transactions (2019)
a=8.5545(3)Å b=8.8157(3)Å c=17.6978(5)Å
α=87.933(3)° β=87.232(3)° γ=63.913(4)°
C32H50Cu2I2N6O4P4
C32H50Cu2I2N6O4P4
Dalton Transactions (2019)
a=9.2630(3)Å b=12.1825(3)Å c=18.6917(7)Å
α=88.319(2)° β=82.651(3)° γ=84.948(2)°
C28H44Cl4Cu4N4O4P4
C28H44Cl4Cu4N4O4P4
Dalton Transactions (2019)
a=14.9560(6)Å b=16.3767(7)Å c=17.6289(7)Å
α=90° β=101.459(4)° γ=90°
C28H44Cu4I4N4O4P4
C28H44Cu4I4N4O4P4
Dalton Transactions (2019)
a=15.4007(6)Å b=16.7327(5)Å c=18.1852(7)Å
α=90° β=113.290(4)° γ=90°
C28H44Br4Cu4N4O4P4
C28H44Br4Cu4N4O4P4
Dalton Transactions (2019)
a=15.3981(9)Å b=16.3342(10)Å c=17.8607(11)Å
α=90° β=113.0690(10)° γ=90°
C32H50Br2Cu2N6O4P4
C32H50Br2Cu2N6O4P4
Dalton Transactions (2019)
a=9.22027(18)Å b=12.2451(2)Å c=18.8242(3)Å
α=86.8260(14)° β=79.3340(16)° γ=84.3383(15)°
C34H58Cl4N4O4P4Pd4
C34H58Cl4N4O4P4Pd4
Dalton Transactions (2019)
a=16.4158(13)Å b=10.4693(7)Å c=17.2657(16)Å
α=90° β=110.152(10)° γ=90°
2-(diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazole]methyl}-1H-imidazole
C31H26N4P2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=8.9713(7)Å b=10.3845(8)Å c=27.663(2)Å
α=90.00° β=90.00° γ=90.00°
5-(Diphenylphosphanyl)-1-{[5-(diphosphanyl)-1H-pyrazol-1-yl]methyl}-1H-pyrazole chloroform solvate
C31H26N4P2,CHCl3
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=12.323(2)Å b=12.892(2)Å c=12.951(2)Å
α=93.945(2)° β=117.423(2)° γ=117.267(2)°
C47H50N4P2Rh2,2(BF4)
C47H50N4P2Rh2,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=15.8580(3)Å b=11.7581(3)Å c=13.3446(3)Å
α=90° β=108.8490(6)° γ=90°
C31H26Cl2N4P2Pd
C31H26Cl2N4P2Pd
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=12.041(4)Å b=18.039(6)Å c=13.169(4)Å
α=90° β=92.438(4)° γ=90°
[1-({2-[diphenyl[selenylidene)-λ^5^-phosphanyl]-1H-imidazol-1-yl}methyl)-1H-imidazol-2-yl]diphenyl-λ^5^-phosphaselenone
C31H26N4P2Se2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=13.078(3)Å b=13.427(3)Å c=16.699(4)Å
α=90° β=103.209(4)° γ=90°
Chlorido(η^5^-cyclopentadienyl)(2-(diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazol-1-yl]methyl}-1H-imidazole-κ^2^P,P)ruthenium(II)
C36H31ClN4P2Ru
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=11.0252(13)Å b=25.073(3)Å c=11.0932(13)Å
α=90° β=90.325(2)° γ=90°
[1-({3-diphenyl(selenylidene)-λ^5^-phosphanyl]-1H-pyrazol-1-yl}methyl)-1H-pyrazol-3-yl]diphenyl-λ^5^-phosphaselenone
C31H26N4P2Se2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=17.6873(6)Å b=9.4183(3)Å c=18.1538(6)Å
α=90° β=109.520(1)° γ=90°
Dichlorido(2-(diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazole]methyl}-1H-imidazole-κ^2^<i>P,P</i>)platinum(II)
C31H26Cl2N4P2Pt
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=12.0662(8)Å b=18.1114(12)Å c=13.1999(9)Å
α=90° β=92.314(1)° γ=90°
C37H36N4P2Pd2,2(BF4),CH2Cl2
C37H36N4P2Pd2,2(BF4),CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=11.1418(5)Å b=31.8019(15)Å c=11.9253(6)Å
α=90° β=102.2500(7)° γ=90°
C36H31ClN4P2Ru
C36H31ClN4P2Ru
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=9.1612(3)Å b=12.9584(5)Å c=15.8185(3)Å
α=98.610(2)° β=92.840(2)° γ=107.317(3)°
C35H31Cl3N6P2Ru
C35H31Cl3N6P2Ru
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=9.4977(3)Å b=18.3954(4)Å c=19.9460(5)Å
α=87.8663(17)° β=79.437(2)° γ=78.663(2)°
4-Methylpyridinium Pentachlorophenolate
C6Cl5O,C6H8N
IUCrJ (2017) 4, 4
a=7.316(6)Å b=8.942(8)Å c=11.763(9)Å
α=70.15(4)° β=84.67(4)° γ=76.24(4)°
<i>cis</i>-Dichlorido(5-(diphenylphosphanyl)-1-{[5-diphenylphosphanyl-1H-1,2,4-triazol-1-yl]methyl}-1H-1,2,4-triazole-κ^2^<i>P,P</i>)palladium(II)
C29H24Cl2N6P2Pd
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=9.9501(3)Å b=24.6633(9)Å c=11.4922(4)Å
α=90° β=98.4310(16)° γ=90°
1-({5-[diphenyl(selenylidene)-λ^5^-phosphanyl]-1H-1,2,4-triazol-1-yl}methyl)-1H-1,2,4-triazol-5-yldiphenyl-λ^5^-phosphaneselone
C29H24N6P2Se2
Dalton transactions (Cambridge, England : 2003) (2016) 46, 1 227-241
a=14.321(3)Å b=11.432(2)Å c=17.924(3)Å
α=90° β=103.979(2)° γ=90°